rdf:type |
|
lifeskim:mentions |
umls-concept:C0086860,
umls-concept:C0150312,
umls-concept:C0205245,
umls-concept:C0205314,
umls-concept:C0205419,
umls-concept:C0220847,
umls-concept:C0679622,
umls-concept:C1332816,
umls-concept:C1335987,
umls-concept:C1533691,
umls-concept:C1705675,
umls-concept:C1882417
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-1-17
|
pubmed:abstractText |
Chemokines are strong candidate genes for outcome of HCV infection. I-TAC is a chemokine known to be involved in the inflammatory process of HCV infection, and its expression is upregulated in chronic hepatitis C (CHC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1386-6532
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
137-43
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15653416-Base Sequence,
pubmed-meshheading:15653416-Cell Line, Tumor,
pubmed-meshheading:15653416-Chemokine CXCL11,
pubmed-meshheading:15653416-Chemokines, CXC,
pubmed-meshheading:15653416-Hepacivirus,
pubmed-meshheading:15653416-Hepatitis C, Chronic,
pubmed-meshheading:15653416-Hepatocytes,
pubmed-meshheading:15653416-Humans,
pubmed-meshheading:15653416-Molecular Sequence Data,
pubmed-meshheading:15653416-Polymorphism, Genetic,
pubmed-meshheading:15653416-Promoter Regions, Genetic,
pubmed-meshheading:15653416-Virus Replication
|
pubmed:year |
2005
|
pubmed:articleTitle |
A novel I-TAC promoter polymorphic variant is functional in the presence of replicating HCV in vitro.
|
pubmed:affiliation |
Infectious Diseases Laboratories and Hanson Institute, Institute of Medical and Veterinary Science, Adelaide, SA 5005, Australia. karla.helbig@adelaide.edu.au
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|